Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2023-10-11 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a company press release providing an update on the launch and progress of a new medical cannabis care platform, MyMedi.ca, by Avicanna Inc. It includes operational details, patient transition statistics, product portfolio information, and forward-looking statements. There are no financial statements, regulatory filings, or detailed financial performance data presented. The content is an operational update rather than a financial report, regulatory filing, or management discussion. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is also not a presentation, call transcript, or governance-related document. The document is best classified as a general regulatory announcement or company update that does not fit into more specific categories, thus falling under Regulatory Filings (RNS).
2023-10-11 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document announces the retirement of Chandra Panchal, PhD from the Board of Directors and the initiation of a search for a new director. It focuses on changes in the company's board composition and includes statements from the CEO and the retiring chairman. There is no financial data, earnings information, or report publication mentioned. The content clearly pertains to management and board changes rather than financial results or regulatory filings. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 5734 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data.
2023-09-02 English
News release - English.pdf
Regulatory Filings
2023-08-15 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-08-14 English
Interim MD&A - English.pdf
Regulatory Filings
2023-08-14 English
News release - English.pdf
Regulatory Filings
2023-08-14 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.